- Correction
- Open access
- Published:
Correction: Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review
BMC Psychiatry volume 24, Article number: 673 (2024)
The Original Article was published on 08 August 2024
Fuentes et al. BMC Psychiatry (2024) 24:551
Following publication of the original article [1], the authors would like to correct the funding statement. The changes have been highlighted in bold typeface.
The incorrect funding statement is:
This work was supported by grants from the Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Fondo de Investigación Sanitaria ISCIII (PI16/00603 and PI20/00029); SCIII-Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS); Red de Investigación en Atención Primaria de Adicciones (RIAPAd), grant number RD21/0009/0001. The funding agencies had no role in study design, data collection, interpretation, and no influence on the writing.
The correct funding statement is:
This work was supported by grants from the Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Fondo de Investigación Sanitaria Instituto de Salud Carlos III -ISCIII- and co-funded by the European Union (PI16/00603). Project “PI20/00029”, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. SCIII-Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS); Red de Investigación en Atención Primaria de Adicciones (RIAPAd), grant RD21/0009/0001, funded by Instituto de Salud Carlos III (ISCIII), and by the European Union NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR). The funding agencies had no role in study design, data collection, interpretation, and no influence on the writing.
The original article [1] has been corrected.
References
Fuentes et al. BMC Psychiatry (2024) Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review (2024) 24:551 https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12888-024-05986-8
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12888-024-05986-8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Fuentes, J., Mayans, J., Guarro, M. et al. Correction: Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review. BMC Psychiatry 24, 673 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12888-024-06132-0
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12888-024-06132-0